$PLMR

Armstrong Mac sold $395K of PLMR (indirect holdings)

Armstrong Mac (CEO and Chairman) sold 3,500 indirectly-held shares of Palomar Holdings, Inc. (PLMR) at an average of $112.96 ($112.72–$113.28, $0.40M total) across 2 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Armstrong Mac
Published Jun 24, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PLMR
Neutral
medium confidence
Mentioned
$PLMR
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLMRNeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size, price range, and confirmation of a pre-arranged 10b5-1 plan, which can influence short-term sentiment but usually not fundamentals.

02

Market read

This is a routine insider-sale disclosure; any trading impact is likely limited to sentiment/positioning rather than a new business catalyst.

03

What to watch

Traders may overreact to insider-sale headlines; the key nuance is the 10b5-1 structure and the relatively small dollar value versus typical institutional flows.

Relevance 3/10Novelty 5/10Timing: after-hours/filing update on 2026-06-24 for the 2026-06-22 sale

Background

The article is an SEC Form 4 insider transaction: Armstrong Mac (CEO and Chairman) sold Palomar Holdings shares on 2026-06-22 under a Rule 10b5-1 plan; the filing was made 2026-06-24.

Company-level read

Ticker impact

$PLMRNeutralMedium confidence
Context

Palomar Holdings CEO/Chairman Armstrong Mac sold $395K of PLMR shares via a 10b5-1 plan on 2026-06-22 at ~$112.96 avg.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived around filing/flow optics.

Evidence & confidence

The disclosure is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Palomar Holdings, Inc.

    Company whose shares were sold by its CEO/Chairman under a 10b5-1 plan.

  • Armstrong Mac

    CEO and Chairman who executed the open-market sale; filing reports indirect holdings and post-transaction share count.

Related articles

$PLMRMed

Palomar Q2 Earnings Call Highlights

Palomar (NASDAQ: PLMR) reported Q2 earnings call highlights, including crop underwriting contributions and a new AI policy administration platform (PLMR.Farm). Management guided a mid- to upper-30% full-year loss ratio, peaking in Q3. The company repurchased 368,719 shares for about $41M, authorized a $0.45 quarterly dividend, and reported $14.3M favorable prior-year reserve development.

$PLMRMedAI 8/10

Palomar Holdings, Inc. Q2 2026 Earnings Call Summary

Palomar Holdings reported record adjusted net income on diversification across earthquake, casualty, and crop. Management raised full-year 2026 adjusted net income guidance to $270 million to $280 million and expects loss ratios to trend to the mid-to-upper 30s. Palomar authorized a $0.45 quarterly dividend and cited conservative reserving, with 84% of casualty reserves as IBNR.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$PLMRMed

Palomar Holdings, Inc. (PLMR): Results of Operations and Financial Condition

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 plmr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Palomar Holdings, Inc. Reports Second Quarter 2026 Results LA JOLLA, Calif. (August 4, 2026) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $52.6 million , or $1.94 per diluted share, f